BOCA RATON, Fla.--(BUSINESS WIRE)--The clinical study of the iGrow® Hair Growth System titled “The growth of human scalp hair in females using visible red light laser and LED sources” is featured in the October 2014 issue of Lasers in Surgery and Medicine, considered the gold standard journal on laser-based technology. The study, led by Raymond J. Lanzafame, M.D., M.B.A., F.A.C.S., a board-certified surgeon and expert in laser applications and laser research, demonstrated the clinical efficacy and safety of the iGrow Hair Growth System’s low-level laser therapy (LLLT) to promote hair growth in women.
The iGrow Hair Growth System, developed by Apira Science, Inc., a pioneer of LLLT for more than a decade, is a highly effective, hands-free LLLT hair growth device. Its patented red light technology treats affected areas of the scalp by energizing unhealthy follicle cells and promoting hair growth. iGrow was recently granted over-the-counter clearance from the FDA for use in males with androgenetic alopecia who have Norwood Hamilton Classifications of IIa to V. The clinical trial for men was recognized as the Best Overall Experimental and Translational Research by the American Society for Laser Medicine & Surgery, Inc. (ASLMS).
Help employers find you! Check out all the jobs and post your resume.